Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion Pharmaceutical Investing
Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure Pharmaceutical Investing
Merck's Investigational Activin Signaling Inhibitor Sotatercept Improved Six-Minute Walk Distance by 40.8 Meters at Week 24 Versus Placebo in Adults with Pulmonary Arterial Hypertension on Background Therapy Pharmaceutical Investing
Merck's MK-0616, an Investigational Oral PCSK9 Inhibitor, Significantly Reduced LDL-C in Patients with Hypercholesterolemia in Phase 2b Study Pharmaceutical Investing
Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets Pharmaceutical Investing
U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems Pharmaceutical Investing
US FDA Approves Intramuscular Administration for Merck's MMRV Family of Vaccines: M-M-RII , VARIVAX , and ProQuad Pharmaceutical Investing
Late-Breaking Data from Landmark COAPT Trial Show Long-Term Benefits of Abbott's MitraClip Device Pharmaceutical Investing
New Data Show Superiority of Abbott's TriClip Device Compared to Medical Therapy for Tricuspid Regurgitation Pharmaceutical Investing
